Your session is about to expire
← Back to Search
Laser Therapy
SeCure Endovenous Laser Treatment Study (SeCure Trial)
N/A
Waitlist Available
Research Sponsored by Angiodynamics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 day
Awards & highlights
No Placebo-Only Group
Summary
The VenaCure EVLT 400 µm Fiber Kit is currently marketed for the treatment of varicose veins. AngioDynamics, Inc., the company that manufacturers the VenaCure device, is sponsoring this study to assess the safety and effectiveness of the VenaCure EndoVenous Laser Treatment (EVLT) 400 µm Fiber Kit for treatment of incompetent perforator veins (IPVs). The VenaCure EVLT 400 µm Fiber Kit has not been previously studied by AngioDynamics for the ablation of IPVs.
Eligible Conditions
- Chronic Venous Insufficiency
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acute Primary Ablation Success
Secondary study objectives
Technical Success
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: VenaCure EVLT 400 µm fiber Procedure KitExperimental Treatment1 Intervention
Only one limb can be treated and included in this study; however, multiple IPV's within the study limb may be treated. All IPV's treated will be followed according to the study schedule.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VenaCure EVLT 400 µm fiber Procedure Kit
2015
N/A
~120
Find a Location
Who is running the clinical trial?
Angiodynamics, Inc.Lead Sponsor
25 Previous Clinical Trials
2,741 Total Patients Enrolled